3 Sheffler LA, Wink DA, Melillo G ,et al. Exogenous nitric oxide regulates iFN-gamma plus lipopolysaccharide-induced nitric oxide synthase expression in mouse macrophages . J Immunol , 1995, 155:886-894.
4 Lopez Talavera JC, Levitzki A, Martinez M, et al. Tyrosine kinase inhibition ameliorates : the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites. J Clin invest, 1997, 100:664-670.
5 Mizumoto M, Arii S, Furutani M, et al. NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced live cirrhosis. J Surg Res, 1997, 70 :124-133.
6 Rockey DC, Chung JJ. Regulation of inducible nitric oxide synthase and nitric oxide hepatic injury and fibrogenesis. Am J Physiol, 1997, 273(1 Pt 1): g124-130.
7 Billiar TR, Curran RD, Stuchr DJ, et al. Evidence that activation of kupffer cells results in production of L-arginine met abolites that release cell-associated iron and inhibit hepatocyte protein synthsis. Surgery, 1989,106:364-372.
8 Bohlinger I, Leist M, Brsig J, et al. Interleukin-1 and nitric oxide protect against tumor necrosis factor alpha-induced liver injury through distinct pathways. Hepatology , 1995, 22:1829-1837.
9 Morales RM, Jimenez M, Ros J, et al. Nitric oxide production by peritoneal macrophages of cirrhotic rats: a host response against bacterial peritonitis. Gastroenterology , 1997, 112:2056-2064.
10 Gasini A, Ceni E, Salzano R, et al. Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide. Hepatology , 1997, 25:361-367.
11 Sharara AI, Perkins DJ, Misukonis MA, et al. Interferon(IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase( NOS) type 2 mRNA and protein expression: possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-alpha in vivo. J Exp Med,1997, 186:1495-1502.
12 Vogl S,Junker U, Vogelsang H,et al. Macrophages from rat livers wit h micronodular and macronodular cirrhosis differ with respect to mediator release and DNA-synthesis. J Hepatol, 1997, 26:1093-1103.
13 Bories PN, Campillo B, Azaou L, et al. Long-lasting NO overproduction in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology, 1997, 25:1328-1333.
14 Kurose I, Higuchi H, Watanabe N, et al. Nitric oxide and tumor necrosis factor-alpha mediate apoptosis of hepatoma cells induced by Kupffer cells. hepatology, 1995, 22(Pt 2):228A.
15 Moriyama A, Masumoto A, Nanri H, et al. High plasma concentrations of nitrite/nitrate in patients with hepatocellular carcinoma. Am J Gastroenterol,1997,92:1520-1523.
16 Fernandez-Rodriguez CM, Prieto J, Quiroga J, et al. Enhanced urinary excretion of cGMP in live cirrhosis relationship to hemodynamic changes, neurohormonal activation, and urinary sodium excretion. Dig Dis Sci, 1997,42:1416-1420.
17 Liption SA, Choi YB, Pan ZH, et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitrose-compounds. nature, 1993, 364:626-632.
18 Schroeder RA, Gu JS, Kuo PC. Interleukin 1β-stimulated&nb sp;production of nitric oxide in rat hepatocytes is mediated through endogenous synthesis of interferon gamma. Hepatology, 1998,27:711-719.
